A national survey reveals variability in asymptomatic bacteriuria management among nephrologists, suggesting evidence gaps.
Significant variability exists in ASB screening and treatment practices among Canadian nephrologists. These findings highlight a true evidence gap regarding management during the early posttransplant period, rather than a failure to adopt established data, and support the need for pragmatic clinical trials to guide evidence-based ASB management and antimicrobial stewardship.
No takes yet. Share an insight, caveat, or question.
Rodriguez‐Ramirez et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: